Journal of Dental Science and Medicine
Open Access

Alzheimer’s disease (AD) is a complex neurodegenerative disorder that is characterized by progressive cognitive decline and the accumulation of amyloid-beta plaques in the brain. The exact etiology of Alzheimer’s disease remains poorly understood, but recent research suggests that chronic infections and inflammation, particularly those arising from the oral cavity, may play a pivotal role in the development of amyloid plaques. Oral pathogens, such as Porphyromonas gingivalis and Fusobacterium nucleatum, are known to induce systemic inflammation and may directly influence the brain's pathophysiology. This article explores the mechanisms through which oral pathogens contribute to amyloid plaque formation and their potential role in the development of Alzheimer’s disease [1- 4].

Amyloid Plaques and Alzheimer’s Disease

Amyloid plaques are extracellular protein aggregates primarily composed of amyloid-beta (Aβ) peptides. These plaques are a hallmark feature of Alzheimer’s disease and are thought to disrupt neuronal communication, leading to neuroinflammation, synaptic dysfunction, and cognitive decline. The accumulation of Aβ plaques is closely linked to the onset and progression of Alzheimer's disease, although the precise mechanisms behind their formation are still under investigation.

Aβ peptides are derived from the amyloid precursor protein (APP), which is cleaved by enzymes such as β-secretase and γ-secretase to release Aβ fragments. Under normal conditions, Aβ peptides are cleared efficiently from the brain; however, in Alzheimer’s disease, a failure in this clearance system results in the accumulation and aggregation of Aβ, leading to plaque formation. The presence of amyloid plaques disrupts the surrounding neural environment, triggering inflammatory responses that exacerbate neuronal damage [5].

Oral Pathogens and Systemic Inflammation

Oral health plays a significant role in overall health, and periodontal diseases, such as chronic periodontitis, are a major source of systemic inflammation. Periodontal pathogens, particularly Porphyromonas gingivalis a bacterium strongly associated with periodontal disease produce various virulence factors that promote inflammation and tissue destruction in the oral cavity. These pathogens can enter the bloodstream through inflamed oral tissues, carrying bacterial toxins and inflammatory mediators throughout the body.

Once in the bloodstream, oral pathogens and their associated toxins, such as lipopolysaccharides (LPS), can travel to distant organs, including the brain. This systemic inflammatory response is thought to contribute to the pathogenesis of Alzheimer’s disease by promoting neuroinflammation, a key feature of AD. Additionally, the chronic presence of oral bacteria and their toxins can disrupt normal immune function, further exacerbating the inflammatory environment in the brain [6].

Amyloid Plaque Formation and Oral Pathogens

Recent research has uncovered a potential link between oral pathogens and the accumulation of amyloid plaques in the brain. One of the mechanisms through which oral pathogens may contribute to amyloid plaque formation is through the activation of the immune response. When oral bacteria such as Porphyromonas gingivalis enter the bloodstream, they trigger the production of pro-inflammatory cytokines and other immune mediators. These molecules can travel to the brain and activate microglial cells resident immune cells in the central nervous system.

Activated microglia release a variety of pro-inflammatory cytokines, which can increase the production of amyloid-beta (Aβ) peptides. In addition to increasing Aβ production, these inflammatory molecules can impair the clearance of Aβ from the brain, contributing to its accumulation and the formation of amyloid plaques. Microglial activation, while a normal immune response to brain injury or infection, can become dysregulated in the case of chronic inflammation, such as that caused by oral pathogens. This dysregulated microglial activation is thought to be one of the key contributors to the persistence of amyloid plaques in Alzheimer’s disease.

Moreover, oral pathogens such as Porphyromonas gingivalis have been shown to interact with the amyloid precursor protein (APP) directly. Studies have found that P. gingivalis can bind to APP, increasing its cleavage and promoting the release of Aβ peptides. This interaction further contributes to the accumulation of amyloid plaques, creating a vicious cycle of inflammation and plaque formation.

The Role of Lipopolysaccharides (LPS) in Amyloid Plaque Formation

One of the primary inflammatory mediators released by oral bacteria, such as Porphyromonas gingivalis and Fusobacterium nucleatum, is lipopolysaccharides (LPS). LPS, a component of the outer membrane of Gram-negative bacteria, is a potent activator of the immune system. When LPS enters the bloodstream, it stimulates the release of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), which can disrupt the normal functioning of the brain’s immune cells, particularly microglia [7- 10].

LPS has been shown to exacerbate neuroinflammation by activating microglia in a manner similar to that seen in Alzheimer's disease. In the presence of LPS, microglia become hyper-activated and produce more inflammatory cytokines, which in turn promote the accumulation of amyloid-beta and increase its deposition in the brain. This process leads to the formation of amyloid plaques, which disrupt neuronal communication and contribute to cognitive decline. In this way, LPS from oral pathogens may serve as a bridge linking periodontal infection and amyloid plaque formation in Alzheimer’s disease.

Oral Pathogens and Blood-Brain Barrier Disruption

Another critical mechanism through which oral pathogens may influence amyloid plaque formation is the disruption of the blood-brain barrier (BBB). The BBB is a selective barrier that regulates the movement of substances between the blood and the brain, protecting the brain from potentially harmful agents. However, systemic inflammation caused by oral pathogens, including LPS, can weaken the BBB, allowing inflammatory mediators and bacteria to enter the brain.

The increased permeability of the BBB may facilitate the entry of amyloid-beta into the brain, promoting the formation of amyloid plaques. Additionally, the breakdown of the BBB can lead to an accumulation of inflammatory cells in the brain, further exacerbating neuroinflammation and accelerating the formation of amyloid plaques. This combination of increased amyloid deposition and chronic neuroinflammation is thought to be a central mechanism in the progression of Alzheimer’s disease.

Potential Therapeutic Implications

The link between oral pathogens and amyloid plaque formation has significant therapeutic implications for Alzheimer’s disease. By addressing oral health, particularly through the treatment of periodontal disease, it may be possible to reduce the systemic inflammation that contributes to amyloid plaque formation. For example, targeting oral pathogens with antimicrobial therapies or improving oral hygiene could help decrease the burden of inflammatory mediators, such as LPS, in the bloodstream and subsequently reduce neuroinflammation in the brain.

Furthermore, strategies aimed at restoring blood-brain barrier integrity and reducing microglial activation may help prevent or slow the progression of Alzheimer’s disease in individuals with periodontal disease. Combining oral health interventions with therapies that target amyloid-beta production or enhance its clearance could provide a promising approach to preventing or treating Alzheimer’s disease.

Conclusion

The growing body of evidence linking oral pathogens to amyloid plaque formation in Alzheimer’s disease underscores the importance of oral health in the prevention and management of neurodegenerative diseases. Oral bacteria, particularly Porphyromonas gingivalis, induce systemic inflammation that activates microglia and promotes the production and accumulation of amyloid-beta peptides in the brain. This process contributes to the formation of amyloid plaques, a key feature of Alzheimer’s disease. Understanding the mechanisms by which oral pathogens influence amyloid plaque formation may open new avenues for early intervention and therapeutic strategies aimed at reducing the risk of Alzheimer’s disease. Maintaining good oral hygiene and addressing periodontal disease could play a significant role in reducing the burden of neurodegeneration and improving cognitive health in aging populations.

1. Abanades S, Abbaspour H, Ahmadi A (2022) A conceptual review of sustainableelectrical power generation from biogas. Energy Sci Eng 10: 630-655.

Google Scholar, Crossref

2. Ambar P, Endang S, Rochijan, Nanung AF, Yudistira S, et al. (2017) Potential test on utilization of cowʼs rumen fluid to increase biogas production rate and methane concentration in biogas. Asian J Anim Sci 11: 82-87.

Google Scholar, Crossref

3. Babel S, Fukushi K, Sitanrassamee B (2004) Effect of acid speciation on solid waste liquefaction in an anaerobic acid digester. Water Res 38: 2416-2422.

Indexed at, Google Scholar, Crossref

4. Chen P, Qinglong X, Addy M, Zhou W, Liu Y, et al. (2016) Utilization of municipal solid and liquid wastes for bioenergy and bioproducts production. Bioresource Technology 215: 163-172.

Google Scholar, Crossref

5. Cun-fang Liu (2008) Prediction of Methane Yield at Optimum pH for anaerobic digestion of Organic Fraction of Municipal Solid Waste. Bioresource Technology 99: 882-888

Indexed at, Google Scholar, Crossref

6. Deepanraj B, Sivasubramanian V, Jayaraj S (2015) Experimental and kinetic study on anaerobic digestion of food waste: The effect of total solids and pH. J Renew Sustain Ener 7: 063-104.

Google Scholar, Crossref

7. EESI (2017) Fact Sheet | Biogas: Converting Waste to Energy.
8. EPA (2016) Municipal Solid Waste.
9. ESMAP (2005) Advancing Bioenergy for Sustainable Development - Guideline for Policy-makers and Investors.
10. Ezekoye VA, Ezekoye BA (2009) Characterization and storage of biogas produced from theanaerobic digestion of cowdung, spent grains/cow dung and cassava peels/rice husk. Pac J sci technol 10: 898-904

Google Scholar